TYSABRI treated

Related by string. * Tysabri : Elan Tysabri . Tysabri Elan . approved Tysabri reintroduction . Biogen Idec Tysabri . Tysabri Biogen Idec . Tysabri monotherapy . Tysabri natalizumab / Treating . treating . Treats . Treated . Treat . TREAT : Treat Diseases Inc. . insecticide treated mosquito nets . insecticide treated nets . sweet treats . insecticide treated bed . treat pulmonary arterial * *

Related by context. Frequent words. (Click for all words.) 67 treatment emergent adverse 66 laboratory abnormalities 64 events SAEs 64 events AEs 63 Adverse events 63 discontinuations due 62 peripheral edema 61 nasopharyngitis 61 thromboembolic events 60 thrombotic events 60 Secondary endpoints 59 hepatotoxicity 59 QT prolongation 59 neuropsychiatric symptoms 59 hypomagnesemia 59 cerebrovascular events 58 lymphopenia 58 Adverse reactions 58 leukopenia 58 thromboembolism 58 febrile neutropenia 58 patients receiving ERBITUX 57 discontinuations 57 hyperkalemia 57 dose limiting toxicities 57 limiting toxicity 57 infusion reactions 57 hypercalcemia 56 SAEs 56 Neutropenia 56 nausea diarrhea 56 myocardial infarction stroke 56 immunosuppressive agents 56 myelosuppression 56 tumor lysis syndrome 56 vasomotor symptoms 56 renal insufficiency 56 comorbid conditions 55 akathisia 55 Postoperative 55 REMICADE ® 55 orthostatic hypotension 55 impaired renal 55 secondary efficacy endpoints 55 lactic acidosis 54 mg BID 54 AEs 54 Elderly Patients 54 LUTS 54 headache dizziness 53 Allergic reactions 53 hypersensitivity reactions 53 exacerbations 53 angioedema 53 spinal cord compression 53 metabolic acidosis 53 P = .# 53 intracerebral hemorrhage 53 urticaria 53 thrombocytopenia 53 RLS symptoms 53 headache nausea 52 Secondary endpoints included 52 etiologies 52 arthralgia 52 cSSSI 52 comorbidities 52 52 PRECiSE 51 hypersensitivity reaction 51 anticholinergics 51 nonresponders 51 pneumonitis 51 gastrointestinal symptoms 51 urinary retention 51 confidence interval CI 51 hypocalcemia 51 affective disorders 51 fasting insulin 51 anaphylactic reactions 51 symptom severity 51 nonsignificant 50 toxicities 50 evaluable 50 PANSS 50 Hypersensitivity 50 antiepileptic drugs 50 Postmenopausal Women 50 telithromycin 50 Adverse Events 50 radiation dermatitis 50 lacosamide 50 cardiac toxicity 50 severe hypoglycemia 49 secondary endpoints 49 HbA1c levels 49 neutropenia 49 IPSS 49 anticonvulsants 49 placebo p = 49 systemic absorption

Back to home page